Streetbeat News

RDUS

Radius Health, Inc.

Industry

Drug Manufacturers - Specialty & Generic

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.

Open

17.42

Mkt cap

475M

Volume

165K

High

17.70

P/E Ratio

-1.82

52-wk high

31.70

Low

17.03

Div yield

0.04

52-wk low

12.69

Schnitzer Steel reported Q2 adjusted losses of $(1.04) per share, surpassing the $(1.09) estimate, but its sales of $621.06M fell short of the $626.15M estimate. This represents a significant decrease in performance compared to the same period last year, with earnings down 842.86% and sales down 17.84%.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 12:08 pm

Earnings reports for April 4, 2024, include a mix of expected profits and losses across various sectors. Notable companies like Conagra Brands, Trinity Biotech, and AngioDynamics are set to report before the bell, with projections ranging from profits to losses. WisdomTree International LargeCap Dividend Fund and others also anticipate earnings, while companies like Conifer Holdings and Movano will report after the bell.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 9:18 am

Cleveland-Cliffs (CLF) considers a bid for U.S. Steel (X) if the Nippon Steel deal fails, amid opposition from government officials including President Biden. Tredegar Corporation (TG) reports a significant net loss for Q4 and full-year 2023. Radius Recycling (RDUS) anticipates a net loss for Q2 2024 but plans cost cuts for efficiency. Steel Dynamics (STLD) projects higher Q1 2024 earnings, supported by strong steel operations and demand across sectors.

Portfolio Pulse from Austin DeNoce

March 15, 2024 | 8:41 pm

Seaport Global analyst Martin Englert maintains a Sell rating on Radius Recycling (NASDAQ:RDUS) and lowers the price target from $17.5 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 5:25 pm

Radius Recycling forecasts a Q2 adjusted EPS from continuing operations between $(1.05) and $(1.10), significantly below the estimated $(0.38). The company expects a net loss of approximately $(35) million, with a loss per share from continuing operations ranging from $(1.19) to $(1.24), and an adjusted EBITDA of about $2 million.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:46 pm

Radius Recycling announced preliminary Q2 results, highlighting challenging market conditions. The company has increased its cost reduction target in response.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:42 pm

Mobileye Global Inc. (MBLY) shares plummeted over 23% after issuing preliminary FY23 financial results and initial 2024 guidance, which were below the previous implied guidance. Wolfe Research analyst Shreyas Patil downgraded the stock from Outperform to Peer Perform. Other stocks experienced significant movement in Thursday's mid-day session, with various companies reporting gains due to positive developments, collaborations, and strategic reviews, while others faced declines due to public offerings, corporate updates, and preliminary financial results.

Portfolio Pulse from Avi Kapoor

January 04, 2024 | 6:37 pm

Schnitzer Steel Industries, Inc. (NASDAQ:RDUS) reported a 12.4% Y/Y increase in Q1 FY24 revenue to $672.89 million, surpassing the $643.35 million consensus. The adjusted loss per share widened to 64 cents, beating the 70 cents consensus. Gross margin fell to $39 million, and operating loss grew to $22.98 million. The company cited challenges such as tighter recycled metal supplies, lower selling prices, and reduced demand from U.S. manufacturing and Asia. Adjusted EBITDA was $1 million, down from $8 million. Ferrous sales volumes rose by 35.4%, but EBITDA per ferrous ton sold dropped to $1. Nonferrous sales increased by 12% due to advanced technologies and an acquisition, while steel sales grew by 10% driven by strong demand in the western U.S. RDUS shares fell by 2.86% to $29.50.

Portfolio Pulse from Akanksha Bakshi

January 04, 2024 | 4:15 pm

Schnitzer Steel's stock is trading lower following the announcement of their Q1 financial results, indicating a negative market reaction to the company's performance.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 4:02 pm

Schnitzer Steel (NASDAQ: SCHN) reported Q1 adjusted EPS of $(0.64), surpassing the $(0.70) estimate, and sales of $672.90M, exceeding the $643.35M estimate. This represents a 45.45% decrease in EPS and a 12.39% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:02 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.